Biophotonics Market
                     Biophotonics Market- Size, Share, Outlook, and Opportunity Analysis, 2020- 
2027
Biophotonics is a branch of science that deals with producing and using the photons of light to
create an image, identify, and engineer biological materials. Biophotonics is a combination of
four major technologies that include lasers, biotechnology, nanotechnology, and photonics. It
has a biomedical application that covers light interactions in medicine and life-science for the
health care sector.
Global biophotonics market was valued at US$ 49.0 billion in 2018 and is predicted to reach
US$ 95.0 billion, growing at a CAGR of 8.3% during the forecast period (2019 to 2027).
Request  a  sample  copy  of  this  report:-  https://www.coherentmarketinsights.com/insight/request-
sample/3191 
Growing awareness regarding better healthcare solutions and increasing government initiatives
to offer beneficial policies in order to boost healthcare and agriculture sectors is projected to
propel the market growth of biophotonic. Moreover, increasing launch of new treatment based
on  biophotonic  is  further  estimated to  foster  market  growth.  For  instance,  in  August  2018,
Kleresca, a medical technology company has announced the launch of a new treatment for
rosacea. It is based on Kleresca’s unique and patented biophotonic technology which utilizes
fluorescent  light  energy  to  stimulate  the  skin’s  own  repair  mechanisms  through  photo  bio
modulation.
The rising number of partnership among major players for developing advanced biophotonic
technology is projected to boost the market growth over the forecast period. For instance, in
June 2017, The Salk Institute’s Waitt Advanced Biophotonics Center and ZEISS announced a
global  partnership  to  accelerate  the  frontiers  of  microscopy  and  imaging  technologies.  The
purpose of this partnership was to develop cutting-edge optical and optoelectronic technologies.
Therefore, the rising number of partnership for developing advanced imaging technology by
using biophotonic is projected to boost market growth. 
North  America  region  dominated  the  global  biophotonics  market  in  2018,  accounting
for 39.2% share in terms of revenue, followed by Europe and Middle East & Africa, respectively.
Patents  and  regulatory  policies  are  major  factor  that  can  impact  the  market  growth  of
biophotonics as most of the drugs are still patented, due to which only certain players can have
the power to generate profit from medical solution. This is projected to hamper market growth
over  the  forecast  period.  Moreover,  biophotonic  is  still  in  the  nascent  phase  and  lack  of
awareness regarding these advanced technologies in underdeveloped regions is expected to
hinder the market growth.
The high cost of biophotonics instrument and treatment is expected to restraint market growth.
Biophotonics instruments are very expensive when compared to its alternatives. Because of its
high cost,  many small  and medium scale enterprises,  as well  as end-users, avoid adopting
biophotonics devices. This is expected to limit the application of biophotonic technology. Hence,
the high cost of the biophotonic is projected to hamper the market growth of biophotonic.
Rising cases of various chronic diseases around the globe such as arthritis, genetic disorders,
cancers, etc. There are nearly 7000 rare diseases that are prevalent around the globe. Out of
which more than 95% of rare disorders don’t get FDA-approved drugs. Biophotonics, being the
most  advanced  technology  aims  to  offer  enhanced  treatment  solutions  for  these  critical
diseases. Therefore, the rising application of biphotonic based treatment solutions for treating
various chronic diseases is projected to offer immense growth opportunity to the market over
the forecast period.
Emerging medical tourism across developing nations is the next big platform that is expected to
offer  enormous growth opportunity over  the forecast  period.  Biophotonics with its advanced
technologies can expand medical tourism in the near future. Moreover, emerging biophotonic
technology is also projected to open new doors of opportunity to the new players to generate
high profits in the market. This factor is also expected to propel the market growth over the
forecast period.
The rising trend of miniature technology to treat various chronic diseases is expected to propel
the market growth over the forecast period. For example, entire devices are used in medicine
that determines the activity of cells, molecules, and fibers by using fluorescent light. But now,
with the advent of biophotonics-on-chip, mini-versions of those same large devices can also be
developed.  Hence,  the rising  trend of  a miniature of  biophotonic  technology is  expected to
propel the market growth over the forecast period.
Rising  efforts  by  various  manufacturers  to  promote  the  biophotonic  technology  in  imaging
diagnostic  solution  is  projected  to  fuel  the  market  growth  over  the  forecast  timeframe.  For
instance, in 2019, ALPhANOV expanded its internal research in the field of biophotonic imaging
for diagnosis and therapy by using its advanced femtosecond fiber laser developments and its
new  modular  microscope.  ALPhANOV  performed  its  first  nonlinear  images  on  biological
samples.
Based on application, global biophotonics market is segregated into see through imaging, inside
imaging, spectro molecular, surface imaging, microscopy, light therapy, biosensors, and other
analytic sensing. In 2018, see through imaging accounted for the substantial share of 27.4% in
global biophotonics market.
Players active in the market are Becton, Dickinson & Co., Affymetrix Inc., Carl Zeiss, Olympus
America, Andor Technology, and Hamamatsu Photonics
Get the main link:-  https://www.coherentmarketinsights.com/market-insight/biophotonics-market-3191
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Visit our news Website: http://www.coherentchronicle.com/